108 related articles for article (PubMed ID: 34907711)
21. Efficacy of intestinal microorganisms on immunotherapy of non-small cell lung cancer.
Xu H; Deng Y; Zhu Q; Li F; Liu N; Cheng J; Qiu M
Heliyon; 2024 May; 10(9):e29899. PubMed ID: 38699020
[TBL] [Abstract][Full Text] [Related]
22. Coronavirus Disease 2019 (COVID-19) Pandemic Lifestyle Changes May Have Influenced Small Bowel Microbial Composition and Microbial Resistance.
Hosseini A; Rashid M; Leite G; Barlow GM; Parodi G; Sanchez M; Ayyad S; Pimentel ML; Morales W; Weitsman S; Pimentel M; Mathur R
Dig Dis Sci; 2023 Oct; 68(10):3902-3912. PubMed ID: 37578565
[TBL] [Abstract][Full Text] [Related]
23. Intestinal dysbiosis as an intraoperative predictor of septic complications: evidence from human surgical cohorts and preclinical models of peritoneal sepsis.
Spari D; Zwicky SN; Yilmaz B; Salm L; Candinas D; Beldi G
Sci Rep; 2023 Dec; 13(1):22921. PubMed ID: 38129468
[TBL] [Abstract][Full Text] [Related]
24. Emergence of rare and low abundant anaerobic gut Firmicutes is associated with a significant downfall of Klebsiella in human colon cancer.
Shastry RP; Ghate SD; Hameed A; Prasad Rao RS; Bhandary YP; Shetty R
Microb Pathog; 2024 Jun; 193():106726. PubMed ID: 38848931
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiome structure and adrenocortical activity in dogs with aggressive and phobic behavioral disorders.
Mondo E; Barone M; Soverini M; D'Amico F; Cocchi M; Petrulli C; Mattioli M; Marliani G; Candela M; Accorsi PA
Heliyon; 2020 Jan; 6(1):e03311. PubMed ID: 32021942
[TBL] [Abstract][Full Text] [Related]
26. Intestinal
Price CE; Valls RA; Ramsey AR; Loeven NA; Jones JT; Barrack KE; Schwartzman JD; Royce DB; Cramer RA; Madan JC; Ross BD; Bliska J; O'Toole GA
mBio; 2024 Feb; 15(2):e0314423. PubMed ID: 38179971
[TBL] [Abstract][Full Text] [Related]
27. Beyond the Bile: Exploring the Microbiome and Metabolites in Cholangiocarcinoma.
Lee J; Kim H; Park JS
Life (Basel); 2024 May; 14(6):. PubMed ID: 38929681
[TBL] [Abstract][Full Text] [Related]
28. Esophageal cancer and bacterial part of gut microbiota - A multidisciplinary point of view.
Muszyński D; Kudra A; Sobocki BK; Folwarski M; Vitale E; Filetti V; Dudzic W; Kaźmierczak-Siedlecka K; Połom K
Front Cell Infect Microbiol; 2022; 12():1057668. PubMed ID: 36467733
[TBL] [Abstract][Full Text] [Related]
29. Alterations in the gut microbiome in patients with esophageal carcinoma in response to esophagectomy and neoadjuvant treatment.
Hasuda H; Ikeda T; Makizaki Y; Yokota H; Tanaka Y; Ohno H; Shimokawa M; Matsuoka H; Kimura Y; Oki E; Yoshizumi T
Surg Today; 2023 Jun; 53(6):663-674. PubMed ID: 36401664
[TBL] [Abstract][Full Text] [Related]
30. Alterations in gut microbiota of esophageal squamous cell carcinoma patients.
Cheung MK; Yue GGL; Lauw S; Li CSY; Yung MY; Ng SC; Yip HC; Kwan HS; Chiu PWY; Lau CBS
J Gastroenterol Hepatol; 2022 Oct; 37(10):1919-1927. PubMed ID: 35816164
[TBL] [Abstract][Full Text] [Related]
31. The gut-brain-axis: A positive relationship between gut microbial dysbiosis and glioblastoma brain tumour.
Ishaq HM; Yasin R; Mohammad IS; Fan Y; Li H; Shahzad M; Xu J
Heliyon; 2024 May; 10(9):e30494. PubMed ID: 38756585
[TBL] [Abstract][Full Text] [Related]
32. Causal analysis of the gut microbiota in differentiated thyroid carcinoma: a two-sample Mendelian randomization study.
Quan Z; Zhang X; Wang S; Meng Y
Front Genet; 2023; 14():1299930. PubMed ID: 38155712
[No Abstract] [Full Text] [Related]
33. Insights into vitamin A in bladder cancer, lack of attention to gut microbiota?
Luo P; Zheng L; Zou J; Chen T; Zou J; Li W; Chen Q; Qian B
Front Immunol; 2023; 14():1252616. PubMed ID: 37711628
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Oesophagogastric Cancer-Associated Microbiome: A Systematic Review and Quality Assessment.
Vadhwana B; Tarazi M; Boshier PR; Hanna GB
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345006
[TBL] [Abstract][Full Text] [Related]
35. The Role of the Microbiota in Esophageal Cancer.
Moreira C; Figueiredo C; Ferreira RM
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174041
[TBL] [Abstract][Full Text] [Related]
36. Awareness of intratumoral bacteria and their potential application in cancer treatment.
Liang Y; Li Q; Liu Y; Guo Y; Li Q
Discov Oncol; 2023 May; 14(1):57. PubMed ID: 37148441
[TBL] [Abstract][Full Text] [Related]
37. A New Treatment Landscape for RCC: Association of the Human Microbiome with Improved Outcomes in RCC.
Piao XM; Byun YJ; Zheng CM; Song SJ; Kang HW; Kim WT; Yun SJ
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765892
[TBL] [Abstract][Full Text] [Related]
38. New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer.
Li Z; Ke X; Zuo D; Wang Z; Fang F; Li B
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615706
[TBL] [Abstract][Full Text] [Related]
39. Quantitative real-time PCR analysis of bacterial biomarkers enable fast and accurate monitoring in inflammatory bowel disease.
Sezgin E; Terlemez G; Bozkurt B; Bengi G; Akpinar H; Büyüktorun İ
PeerJ; 2022; 10():e14217. PubMed ID: 36275453
[TBL] [Abstract][Full Text] [Related]
40. Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment.
Xu H; Cao C; Ren Y; Weng S; Liu L; Guo C; Wang L; Han X; Ren J; Liu Z
Front Immunol; 2022; 13():949490. PubMed ID: 36177041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
